| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $87.59 | $24.37 | 259.44% | 165.26x | 42.09x | 11.11x | 13.42x | 1.20x | $106.92M | 1.16% | $705.78M | 6.70 | $9.37B | 1,193.97 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $31.68 | $8.33 | 280.29% | 150.86x | 72.69x | 8.91x | 18.05x | 1.29x | $39.15M | 0.95% | $220.58M | 1.69 | $4.06B | 89.48 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $226.79 | $81.66 | 177.73% | 37.18x | 34.25x | 6.31x | 22.41x | 1.28x | $793.95M | 2.62% | $1.35B | 10.14 | $31.63B | 26.82 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $89.20 | $15.95 | 459.22% | 83.36x | 75.52x | 8.23x | 10.64x | 2.44x | $182.84M | 2.64% | $654.15M | 8.43 | $6.79B | 56.63 | ||
| KRYS | KRYSTAL BIOTECH INC | $320.58 | $76.47 | 319.22% | 38.76x | 43.12x | 21.49x | 6.98x | 2.54x | $257.78M | 2.72% | $1.36B | 46.03 | $9.07B | 38.88 | ||
| HALO | HALOZYME THERAPEUTICS INC | $128.50 | $71.71 | 79.19% | 36.10x | 14.26x | 9.06x | 101.60x | 0.70x | $806.22M | 5.35% | $143.54M | 1.22 | $16.57B | 23.06 | ||
| VCEL | VERICEL CORP | $43.27 | $8.10 | 433.90% | 90.15x | 76.77x | 7.22x | 5.99x | 2.21x | $61.66M | 2.79% | $370.04M | 7.25 | $2.18B | 49.56 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.35 | $19.63 | 181.99% | 145.66x | 23.35x | 3.14x | 1.69x | 0.93x | $738.18M | 6.89% | $6.32B | 32.68 | $14.03B | 36.37 | ||
| RPRX | ROYALTY PHARMA PLC | $65.28 | $36.92 | 76.82% | 34.72x | 12.03x | 11.46x | 3.84x | 0.69x | $2.92B | 10.06% | $9.79B | 21.99 | $45.69B | 38.85 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.06 | $7.71 | 30.40% | 10.58x | 9.24x | 4.37x | 2.74x | 0.92x | $82.01M | 13.78% | $217.65M | 3.68 | $453.28M | 5.86 | ||
| TGTX | TG THERAPEUTICS INC | $56.44 | $22.70 | 148.59% | 18.32x | 55.06x | 10.01x | 14.30x | 2.04x | $17.39M | 0.22% | $604.08M | 4.26 | $8.91B | 63.99 | ||
| ADMA | ADMA BIOLOGICS INC | $11.17 | $7.07 | 58.00% | 15.51x | 14.04x | 4.98x | 6.13x | 0.90x | $116.47M | 4.57% | $408.21M | 1.79 | $2.56B | 11.00 | ||
| EXEL | EXELIXIS INC | $65.35 | $30.82 | 112.05% | 19.86x | 19.81x | 6.73x | 8.78x | 1.27x | $1.17B | 7.15% | $1.84B | 7.35 | $16.08B | 14.78 | ||
| MDXG | MIMEDX GROUP INC | $3.90 | $1.18 | 231.35% | 97.50x | -21.64x | 1.62x | 2.63x | 1.18x | $44.50M | 7.72% | $216.00M | 1.46 | $449.83M | 19.72 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $311.73 | $87.43 | 256.53% | 30.96x | 32.85x | 21.53x | 6.42x | 2.32x | $130.62M | 2.09% | $967.52M | 48.22 | $6.34B | 22.72 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $206.78 | $192.10 | 7.64% | 13.55x | 13.58x | 2.84x | 2.80x | 0.51x | $1.62B | 12.39% | $4.80B | 75.98 | $16.20B | 10.02 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $521.03 | $150.14 | 247.02% | 30.07x | 27.28x | 10.50x | 6.52x | 2.26x | $3.80B | 2.87% | $20.25B | 79.81 | $127.89B | 23.24 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.95 | $31.43 | 20.75% | 12.09x | 9.12x | 2.29x | 2.21x | 0.68x | $354.90M | 16.14% | $999.24M | 17.25 | $1.81B | 6.48 | ||
| UTHR | UNITED THERAPEUTICS CORP | $591.20 | $209.83 | 181.75% | 19.55x | 21.83x | 7.98x | 3.96x | 2.60x | $1.09B | 4.34% | $6.40B | 150.24 | $23.55B | 14.05 | ||
| TECH | BIO-TECHNE CORP | $72.60 | $16.53 | 339.29% | 62.05x | 34.94x | 9.32x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.41B | 32.82 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $816.10 | $434.01 | 88.04% | 19.46x | 13.64x | 5.40x | 2.65x | 1.03x | $3.76B | 4.48% | $31.71B | 308.48 | $84.27B | 14.66 | ||
| VCYT | VERACYTE INC | $50.28 | $11.86 | 324.01% | 34.92x | 25.92x | 7.16x | 2.91x | 2.94x | $165.99M | 4.13% | $1.39B | 17.36 | $3.78B | 27.07 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.14 | $1.41 | -18.94% | 8.14x | -2.57x | 1.41x | 1.50x | 0.45x | $19.58M | 29.65% | $44.20M | 0.76 | $17.66M | 2.31 | ||
| INCY | INCYTE CORP | $116.60 | $58.56 | 99.11% | 14.36x | 36.83x | 4.01x | 3.73x | 1.70x | $1.92B | 8.22% | $6.34B | 31.66 | $19.68B | 9.52 |